Infertility

Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech

Retrieved on: 
Wednesday, November 15, 2023
Principal, Assistant, Woman, PMCB, Lehigh University, FDA, Infertility, Lead, The Co Founder, Birth control, Pharmaceutical industry, Management

ATLANTA, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead, late-clinical stage product candidate and innovative therapeutic and diagnostic products, today announced a strategic upfront investment of $6.85 million by public biotech company, PharmaCyte Biotech, Inc. (Nasdaq: PMCB) and other healthcare investors.

Key Points: 
  • “We are thrilled to announce this strategic investment, which coupled with other recent financing activities, will allow Femasys to commercialize our infertility-related products, FemaSeed® and FemVue®.
  • As part of the terms of the investment, seasoned life sciences executive, Joshua Silverman, current interim chief executive officer of PharmaCyte, will be joining the Femasys board of directors.
  • Ms. Lee-Sepsick continued, “This strategic investment includes the addition of Mr. Silverman to our Board of Directors, which further aligns with our interests.
  • Previously, he served as Co-Chief Investment Officer of Iroquois from 2003 until 2016 and Co-Chief Investment Officer of Vertical Ventures, LLC from 2000 to 2003.

Immusoft Administers the First Engineered B Cell in a Human Clinical Trial

Retrieved on: 
Friday, December 15, 2023
Biotechnology, Pharmaceutical, Health, Clinical Trials, Disease, Regenerative medicine, Research, IDUA, MPS I, MPS, Therapy, Immunosuppression, Risk, Clinical trial, CIRM, Patient, ISP, Sugar, Division, Pediatric Blood & Cancer, Heart, DSM-IV codes, Infertility, Nausea, Infection, University, Cell, Hair loss, Pharmaceutical industry, Vaccine

Neither chemotherapy nor immunosuppression is required by Immusoft’s novel engineered B cell approach.

Key Points: 
  • Neither chemotherapy nor immunosuppression is required by Immusoft’s novel engineered B cell approach.
  • Immusoft has pioneered B cell engineering to create biofactories for durable in vivo therapeutic protein delivery, leading the field with over 60 issued and pending patents.
  • “Immusoft is advancing the world’s first engineered B cell therapy, which may have significant impact for patients with this rare disease and potentially many others.
  • We are excited by the potential of expanding the Immusoft engineered B cell platform to trials in additional therapeutic areas,” said Robert Sikorski, M.D., Ph.D., Chief Medical Officer, Immusoft.

Freya Biosciences Announces $38 Million Funding in One of the Largest Series A Raises to Advance Women’s Reproductive Immunotherapies

Retrieved on: 
Tuesday, December 12, 2023
Women, Biotechnology, Pharmaceutical, Health, Baby, Maternity, Consumer, Clinical Trials, Other Health, Freyja, Woman, Investment fund, ART, ARCH Venture Partners, Disease, Sofinnova, Export, Infertility, Birth control

Freya Biosciences, a trans-Atlantic biotech company specializing in women's health, announced today a $38 million Series A financing – one of the largest raises to advance women’s reproductive immunotherapies.

Key Points: 
  • Freya Biosciences, a trans-Atlantic biotech company specializing in women's health, announced today a $38 million Series A financing – one of the largest raises to advance women’s reproductive immunotherapies.
  • “We are very excited to announce Freya’s Series A fundraise, with the support of this dedicated team of investors,” said Colleen Acosta, CEO of Freya Biosciences.
  • “Conditions that disproportionately and differently affect women have traditionally been underfunded in proportion to its burden on human health.
  • The funding will also advance Freya’s multi-omics data science platform, which includes deep microbiome sequencing and vast multiplexed immune biomarker profiling in human clinical samples.

YourChoice Therapeutics begins first-in-human trial for male birth control pill

Retrieved on: 
Wednesday, December 13, 2023
Biotechnology, Pharmaceutical, Men, Health, Baby, Maternity, Consumer, Clinical Trials, Other Health, Quotient, Woman, Health equity, Research, Condom, Hormone, Testosterone, Safety, Therapy, Risk, Cardiovascular disease, Mouse, Pregnancy, Vitamin A, Vasectomy, Male, Pharmacokinetics, Weight gain, Infertility, Birth, Testicle, University, Trial of the century, Development, Aggression, Bangladesh Technical Education Board, Rat, Libido, Volunteering, Acne, Birth control, Pharmacy

YourChoice Therapeutics, Inc., a pioneer of hormone-free family planning products, began dosing male volunteers in a phase one clinical study of YCT-529, a drug candidate designed to offer the first hormone-free male birth control pill.

Key Points: 
  • YourChoice Therapeutics, Inc., a pioneer of hormone-free family planning products, began dosing male volunteers in a phase one clinical study of YCT-529, a drug candidate designed to offer the first hormone-free male birth control pill.
  • While a male birth control pill has been a vision for decades, current drug candidates in clinical development use hormonal agents that suppress testosterone to prevent sperm production.
  • We thank our investors and the male volunteers who have stepped forward to be a part of this mission.”
    The Male Contraceptive Initiative has contributed generous funding to the development of the first hormone-free male birth control pill since its inception.
  • The first human study for a hormone-free male birth control pill is a long-awaited milestone and a landmark achievement in the quest for reproductive autonomy.

Pacific Northwest Fertility Center, an Ivy Fertility Clinic Hires Dr. Hanh N. Cottrell

Retrieved on: 
Wednesday, December 6, 2023
Nursing, Health, Hospitals, Other Health, Managed Care, General Health, Pharmaceutical, Pacific Northwest, University, McMurtrie, Patient, Cognitive science, System, Infertility, Antonio Toledo Corro, MD, Philip, Physician, Birth control, Science

Ivy Fertility, a collaborative network of globally-renowned fertility clinics, has welcomed Hanh N. Cottrell, MD to its team of physicians at Pacific Northwest Fertility.

Key Points: 
  • Ivy Fertility, a collaborative network of globally-renowned fertility clinics, has welcomed Hanh N. Cottrell, MD to its team of physicians at Pacific Northwest Fertility.
  • “We are so proud to welcome Dr. Cottrell to our team,” said Julie Lamb, MD, medical director at Pacific Northwest Fertility.
  • “I’m sincerely excited to be joining the like-minded, compassionate, and creative individuals at PNWF and Ivy Fertility,” said Dr. Cottrell.
  • “I believe every patient deserves a personalized touch to their fertility care and am looking forward to providing that as a member of the Pacific Northwest Fertility team.”

Power Home Remodeling Earns Spot on Great Place to Work®’s 2023 Best Workplaces for Parents List

Retrieved on: 
Friday, December 1, 2023
Software, Architecture, Other Energy, Alternative Energy, Energy, Other Construction & Property, Technology, Residential Building & Real Estate, Construction & Property, Engineering, Building Systems, Other Technology, Parent, Family, Parental leave, Infertility, Power, Environment, Life, PEOPLE, Home, Management, Nursing

Power Home Remodeling (“Power”), the nation’s leading exterior home remodeler, and the Fortune #13 Best Company to Work For today announced that it has earned a spot on Great Place To Work®’s 2023 Best Workplaces for Parents List , coming in at #65.

Key Points: 
  • Power Home Remodeling (“Power”), the nation’s leading exterior home remodeler, and the Fortune #13 Best Company to Work For today announced that it has earned a spot on Great Place To Work®’s 2023 Best Workplaces for Parents List , coming in at #65.
  • This marks Power’s fourth time on the list, establishing the organization as one of the best places to work for parents in the country, year after year.
  • “It’s hard to give your all for a company when you struggle to care for your family,” says Michael C. Bush, CEO of Great Place To Work.
  • For those looking for a fulfilling career at one of the country’s top workplaces, can explore open opportunities at apply.workatpower.com/job in Power’s 19 locations nationwide.

Fertility Expert Dr. Banafsheh Kashani Shares Advice for Couples Trying to Conceive this Holiday Season

Retrieved on: 
Thursday, November 30, 2023
Other Health, Practice Management, Physical Therapy, Managed Care, Other Consumer, General Health, Women, Parenting, Men, Fitness & Nutrition, Children, Baby, Maternity, Family, Vitamins, Supplements, Consumer, Health, Well, Holiday, Stress management, Nutrition, Folate, Woman, Pressure, Menstrual cycle, Antioxidant, Human Reproduction (journal), Infertility, Meditation, Nutrient, Communication, Human, Reproduction, Survival, CDC, Mindfulness, FIRST, Knowledge, Empathy, Tourism, Birth control

Banafsheh Kashani , M.D., double board-certified OB-GYN, reproductive endocrinologist, and infertility specialist, offers expert guidance for couples embarking on the journey of conception during this time.

Key Points: 
  • Banafsheh Kashani , M.D., double board-certified OB-GYN, reproductive endocrinologist, and infertility specialist, offers expert guidance for couples embarking on the journey of conception during this time.
  • "The holidays are a popular time for couples to begin their journey of trying to conceive, but there can be added pressure, especially if dealing with infertility,” said Dr. Kashani.
  • "To navigate this process successfully, couples should start by seeking knowledge and resources to ensure they have the most accurate and helpful information.”
    Dr. Kashani offers insights for couples trying to conceive during the holidays, from nutrition and stress management to products to consider.
  • Stress Management: Navigate the holiday hustle with effective strategies to minimize stress and create a fertility-friendly environment.

HRC Fertility Unveils First-Ever IVF Treatment Giveaway in Celebration of Its 35th Anniversary

Retrieved on: 
Wednesday, November 29, 2023
Women, Parenting, Children, Baby, Maternity, LGBTQ+, Family, Health, Consumer, General Health, HRC, Physician, Infertility, IVF, Fertility clinic, Pharmaceutical industry, Auction

HRC Fertility Center (HRC), one of Southern California’s most trusted fertility clinics, announced the launch of its first-ever IVF Treatment Giveaway.

Key Points: 
  • HRC Fertility Center (HRC), one of Southern California’s most trusted fertility clinics, announced the launch of its first-ever IVF Treatment Giveaway.
  • The inspiration behind this giveaway stems from HRC’s mission to make high-quality fertility treatment accessible and attainable for all deserving individuals and families.
  • Since announcing its more affordable anniversary specials in late July, HRC has sold nearly 1,000 egg freezing packages.
  • The IVF Treatment Giveaway offers three lucky individuals/families the chance to win the following prizes:
    First prize: $20,000 worth of services at an HRC location of your choice, including IVF treatment.

UKG Ranks #3 Best Place to Work in IT

Retrieved on: 
Wednesday, November 29, 2023
DEI (Diversity, Equity and Inclusion), Software, Human Resources, Data Management, Accounting, Professional Services, Technology, Fintech, Woman, Black, Erg, Organization, Computerworld, BUILD, Workforce, HCM, Culture, UKG, Trust, Spark, Career development, Caregiver, Friends, Infertility, Veteran, NEST, Spouse, HR, Diversity, Parent, DEI, Life, Female, Policy, Management, Tourism

The annual recognition honors top organizations that challenge their IT staff with purposeful and meaningful careers while providing great benefits and compensation.

Key Points: 
  • The annual recognition honors top organizations that challenge their IT staff with purposeful and meaningful careers while providing great benefits and compensation.
  • Participants present working concepts to a panel of UKG leaders, and the winning projects are often added to the UKG product roadmap.
  • “UKG strives to help every organization become a great place to work, and that mission shows up in the ways we value, respect, and care for our U Krewers every day,” said Scott Howitt, chief digital officer at UKG.
  • “Just as we’re committed to providing our 80,000 customers across industries with innovative HCM solutions that help create top workplaces for their employees, we’re equally focused on making UKG the best place to work for our more than 15,000 U Krewers across the globe — including the hundreds who work in enterprise-technology roles.”

Utah Fertility Center, an Ivy Fertility Clinic, Hires Dr. Yetunde Ibrahim

Retrieved on: 
Tuesday, November 28, 2023
Health, Consumer, Women, Genetics, Baby, Maternity, General Health, Lincoln University, Patient, Harvard Medical School, Practice, Infertility, University, MD, Physician, Hedera, Nursing, Chemistry

Ivy Fertility, a collaborative network of globally-renowned fertility clinics, welcomes Yetunde Ibrahim, MD to its team of physicians at Utah Fertility Center.

Key Points: 
  • Ivy Fertility, a collaborative network of globally-renowned fertility clinics, welcomes Yetunde Ibrahim, MD to its team of physicians at Utah Fertility Center.
  • “We are proud that Dr. Ibrahim has joined our team of reproductive endocrinologists,” said Dierdre Conway, MD, Practice Director at Utah Fertility Center.
  • Her skill and kindness made her a natural fit for Utah Fertility Center.”
    Dr. Ibrahim brings a wealth of past experience and expertise to the Ivy network.
  • “I am delighted to join the team at Utah Fertility Center and continue to provide personalized and compassionate care to our patients,” said Dr. Ibrahim.